These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12544268)

  • 1. Stem cell transplantation for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Curr Opin Pediatr; 2003 Feb; 15(1):24-31. PubMed ID: 12544268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell transplantation and gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Curr Hematol Rep; 2005 Mar; 4(2):126-31. PubMed ID: 15720961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
    Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplantation in hemoglobinopathies.
    Yesilipek MA
    Hemoglobin; 2007; 31(2):251-6. PubMed ID: 17486508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
    Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies.
    Yesilipek MA
    Hemoglobin; 2020 Nov; 44(6):377-384. PubMed ID: 33050763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in allogeneic stem cell transplantation for hemoglobinopathies.
    Al Jefri AH
    Hemoglobin; 2011; 35(5-6):469-75. PubMed ID: 21967642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Era for Hemoglobinopathies: More Than One Curative Option.
    Psatha N; Papayanni PG; Yannaki E
    Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.
    Soni S; Boulad F; Cowan MJ; Scaradavou A; Dahake J; Edwards S; Walters MC
    Pediatr Blood Cancer; 2014 Sep; 61(9):1690-4. PubMed ID: 24803091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment.
    Kohne E
    Dtsch Arztebl Int; 2011 Aug; 108(31-32):532-40. PubMed ID: 21886666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
    Sii-Felice K; Giorgi M; Leboulch P; Payen E
    Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic transplantation for haemoglobinopathies.
    Vassiliou G; Amrolia P; Roberts IA
    Best Pract Res Clin Haematol; 2001 Dec; 14(4):807-22. PubMed ID: 11924923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to setup a successful transplant program for hemoglobinopathies in developing countries: The Cure2Children approach.
    Faulkner L
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):71-75. PubMed ID: 32201151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusing children with hemoglobinopathies.
    Allali S; Taylor M; Albinni S; Amiranoff D; de Montalembert M
    Transfus Clin Biol; 2019 Sep; 26(3):147-149. PubMed ID: 31300265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
    Leonard A; Bertaina A; Bonfim C; Cohen S; Prockop S; Purtill D; Russell A; Boelens JJ; Wynn R; Ruggeri A; Abraham A
    Cytotherapy; 2022 Mar; 24(3):249-261. PubMed ID: 34879990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease.
    Leonard A; Tisdale JF; Bonner M
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):769-795. PubMed ID: 35773052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.
    Bernaudin F; Pondarré C; Galambrun C; Thuret I
    Adv Exp Med Biol; 2017; 1013():89-122. PubMed ID: 29127678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.
    Bhatia M; Walters MC
    Bone Marrow Transplant; 2008 Jan; 41(2):109-17. PubMed ID: 18059330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalassemia and related hemoglobinopathies.
    Sarnaik SA
    Indian J Pediatr; 2005 Apr; 72(4):319-24. PubMed ID: 15876761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.